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Transcriptional Repression of miR-34 Family
Contributes to p63-Mediated Cell Cycle
Progression in Epidermal Cells
Dario Antonini1, Monia T. Russo1, Laura De Rosa1,2, Marisa Gorrese1, Luigi Del Vecchio1,3
and Caterina Missero1,2
p63, a p53 family member, is highly expressed in the basal proliferative compartment of the epidermis and its
expression has been correlated with the growth ability and regenerative capacity of keratinocytes. In this study
we report a mechanism through which p63 maintains cell cycle progression by directly repressing miR-34a and
miR-34c. In the absence of p63, increased levels of miR-34a and miR-34c were observed in primary keratinocytes
and in embryonic skin, with concomitant G1-phase arrest and inhibition of the cell cycle regulators cyclin D1
and cyclin-dependent kinase 4 (Cdk4). p63 directly bound to p53-consensus sites in both miR-34a and miR-34c
regulatory regions and inhibited their activity. Concomitant downregulation of miR-34a and miR-34c
substantially restored cell cycle progression and expression of cyclin D1 and Cdk4. Our data indicate that
specific miR-34 family members have a significant role downstream of p63 in controlling epidermal cell
proliferation.
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INTRODUCTION
The epidermis, which is the outer layer of the skin, is a
stratified epithelium that is continuously renewed by a finely
tuned balance between proliferation and differentiation. p63
is expressed in epithelial cells with high clonogenic capacity
(Yang et al., 1998; Parsa et al., 1999; Pellegrini et al., 2001;
Senoo et al., 2007), and its expression has been correlated
with their proliferative potential (Deyoung et al., 2006;
Truong et al., 2006; Senoo et al., 2007). Mice that are
homozygous for a disrupted p63 gene have major defects in
the development of various stratified epithelia (Yang et al.,
1998, 1999; Mills et al., 1999), consistent with a crucial role
of p63 in these tissues.
p63 encodes a tetrameric transcription factor character-
ized by six isoforms with different transactivation potentials
sharing an identical DNA-binding domain (Yang et al., 1999).
The DNp63a, which is the most abundant isoform in cultured
keratinocytes and epidermis (Yang et al., 1998), contains
both a transactivation domain and an inhibitory domain, and
it has been shown to activate or repress gene transcription
depending on the promoter context (Yang et al., 1998; Serber
et al., 2002). The DNA-binding domain of p63 is highly
homologous to that of p53, and—for this reason—p63 binds
in vitro and in vivo to a consensus sequence that is very
similar to the p53 binding site (Osada et al., 2005; Yang et al.,
2006; Perez and Pietenpol, 2007; Della Gatta et al., 2008),
thus regulating a subset of known p53 target genes (Dohn
et al., 2001; Ellisen et al., 2002; Westfall et al., 2003; Ihrie
et al., 2005).
Among other functions, p53 has a crucial role in
negatively regulating cell cycle progression upon DNA
damage and oncogene-induced senescence by transcrip-
tional regulation of several cell cycle genes (for review, see
Riley et al., 2008). p53-dependent cell cycle arrest in G1
phase is mediated, at least in part, by transcriptional
activation of the cyclin-dependent kinase inhibitor p21Cip1
(Cdkn1a) gene, encoding an inhibitor of G1 cyclin/CDK
complexes (Harper et al., 1993; el-Deiry et al., 1993;
Brugarolas et al., 1995; Waldman et al., 1995). Conversely,
p63 is required for cell cycle progression at least in cultured
human epidermal cells and it has been shown to suppress the
p21Cip1 by binding to the p53-consensus site (Westfall et al.,
2003; Goodheart et al., 2005; Deyoung et al., 2006; Nguyen
et al., 2006; Truong et al., 2006). However, in human
keratinocytes, downregulation of p21Cip1 is unable to fully
restore cell cycle progression in the absence of p63 (Truong
et al., 2006), suggesting that other mechanisms may be
involved. An involvement of p63 in controlling cell cycle
progression in mouse keratinocytes has not been analyzed;
however, p63 has been correlated to the proliferative
potential of human and rat epidermal stem cells (Senoo
et al., 2007).
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MicroRNAs (miRNAs) form a class of small non-coding
RNAs (B19–24 nucleotides) that have key roles in the
regulation of gene expression in several cellular processes,
including cell proliferation. Each miRNA is predicted to bind
to more than 100 target mRNAs and to inhibit gene
expression either by interfering with translation or by
destabilizing the target mRNA (for review, see Bartel, 2009).
Recent studies have shown that members of the miR-34
family possess anti-proliferative potential and induce cell
cycle arrest, senescence, and/or apoptosis (Bommer et al.,
2007; Chang et al., 2007; Corney et al., 2007; He et al.,
2007; Raver-Shapira et al., 2007; Tarasov et al., 2007;
Tazawa et al., 2007). In mammalians, the miR-34 family
comprises three processed miRNAs that are encoded by two
different genes: miR-34a is encoded by its own primary
transcript, whereas miR-34b and miR-34c share common
primary transcripts. In addition, miR-34a and miR-34b/c are
direct transcriptional targets of p53. Transcriptional activa-
tion of miR-34a and miR-34b/c causes dramatic reprogram-
ming of gene expression and contributes to p53-mediated cell
cycle arrest and apoptosis (Chang et al., 2007; Raver-Shapira
et al., 2007). miR-34 family mediates such functions through
additive or synergistic effects on multiple targets, including
cyclin-dependent kinase 4 (CDK4), CDK6, E2F3, cyclin D1,
cyclin E2, Bcl2, and others (Bommer et al., 2007; He et al.,
2007; Tazawa et al., 2007; Sun et al., 2008).
In this study we show that one of the mechanisms by
which p63 regulates cell cycle progression in mouse
epidermal cells is by directly repressing the expression of
two members of the miR-34 family. In the absence of p63,
high expression levels of miR-34a and miR-34c were
observed both in vitro and in vivo. Moreover, concomitant
suppression of miR-34a and miR-34c by specific antisense
inhibitors induces reactivation of cell proliferation and
transition from G1 to S phase in p63 knockdown keratino-
cytes, showing that these miRNAs exert an effect downstream
of p63 to regulate cell cycle progression.
RESULTS
p63 positively regulates cell proliferation of mouse epidermal
cells in a p53-independent manner
p63 is required for human keratinocyte proliferation with a
mechanism that remains poorly understood. To test whether a
similar requirement for p63 in cell cycle progression occurs
in mouse also, primary murine keratinocytes were transfected
with two independent p63-specific small interfering RNA
(siRNAs), and their rate of DNA synthesis was detected using
BrdU incorporation. Loss of p63 resulted in cell proliferation
defect as BrdU incorporation was strongly reduced in p63
knockdown keratinocytes versus control at 48 hours after
transfection (Figure 1a, left panel, and data not shown),
although a small fraction of p63-negative cells were still able
to incorporate BrdU (see Supplementary Figure S1 online).
DNp63a is the predominant p63 isoform expressed in basal
epidermal cells both in vitro and in vivo. An increased
number of cells incorporating BrdU was detected in mouse
keratinocytes infected with a retrovirus carrying DNp63a
(Figure 1a, right panel), confirming the ability of DNp63a to
promote cell proliferation. Flow cytometry analysis revealed
that p63 knockdown resulted in a significant increase in the
percentage of cells in the G1 phase and a concomitant
reduction of cells in S phase, whereas the G2/M phase
remained largely unaffected (Figure 1b), consistent with a
G1-phase arrest in the absence of p63.
To determine whether the cell cycle arrest in the absence
of p63 was dependent on p53, DNA synthesis was measured
in p53-null primary keratinocytes in the presence or absence
of p63. p63 knockdown elicited a similar negative effect on
DNA synthesis in p53-null keratinocytes and in their wild-
type counterparts (Figure 1c), indicating that p53 is not
required for p63-mediated cell cycle arrest at least in mouse
keratinocytes. To analyze the relevance of these findings in a
more physiological context, the role of p63 and p53 in cell
proliferation was assessed in embryonic epidermis. BrdU
in vivo labeling was performed in embryos carrying a
deletion of p63, p53, or both, and compared with wild-type
embryos. A significant reduction in DNA synthesis was
observed in the epidermis of p63-null embryos at embryonic
day 14.5 (E14.5) (Figure 1d), whereas p53 depletion did not
affect the rate of DNA synthesis in either the presence or
absence of p63. Taken together, these data reveal that p63
positively regulates progression through the G1 phase in a
p53-independent manner in both cultured murine keratino-
cytes and embryonic skin.
miR-34a and miR-34c are transcriptionally repressed by p63
To explore the mechanisms underlying cell cycle arrest as a
consequence of the absence of p63, we tested the expression
of a subset of G1-phase cell cycle regulators at different times
upon p63 knockdown (Figure 1e). Low protein levels of
cyclin D1 were detected at early times upon p63 knockdown.
Interestingly, p21Cip1 was not induced by p63 knockdown in
the CD1 keratinocytes in contrast to what was previously
reported in human keratinocytes and in keratinocytes derived
from other mouse strains (Westfall et al., 2003; Deyoung
et al., 2006; Nguyen et al., 2006; Truong et al., 2006), further
supporting the hypothesis that other mechanisms may be
involved in mediating cell cycle arrest in the absence of p63.
At 48 hours after transfection, all tested cell cycle regulators
were downregulated in the absence of p63, possibly as a
consequence of cell cycle arrest.
Recent studies have shown that cyclin D1 protein
expression is regulated by several miRNAs, including miR-
34a (Sun et al., 2008). As miR-34 family is directly regulated
by p53 in many cell types (Chang et al., 2007; He et al.,
2007; Raver-Shapira et al., 2007; Tarasov et al., 2007) and
p63 can bind to p53-consensus sequences, we speculated
that p63 might regulate miR-34 family in keratinocytes. We
first measured the expression of miR-34 family in newborn
primary keratinocytes and skin. miR-34a was previously
reported to be highly represented in a small RNA library from
mouse epidermis at E17.5 (Yi et al., 2006), whereas no
expression studies were performed for miR-34b and miR-34c
in the skin. Expression of miR-34 family members was
measured by TaqMan reverse transcriptase-PCR using spe-
cific miRNA probes. miR-34a was strongly expressed in
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primary mouse keratinocytes, whereas miR-34c was ex-
pressed at lower levels, and miR-34b was undetectable
(Figure 2a). miR-34 expression in keratinocytes paralleled the
expression in newborn skin, as assessed using in situ
hybridization. miR-34a was readily detectable in the epider-
mis and to a lesser extent in the hair follicle with the signal
being stronger in the suprabasal layers than in the basal layer
(Figure 2c). In contrast, miR-34c was less expressed and
mainly detected in the basal layer, whereas miR-34b was
undetectable.
To test the possibility that miR-34 family may be a p63
target, we measured miR-34 expression levels in the presence
or absence of p63 in vitro and in vivo. Induced expression
levels of miR-34a and miR-34c were observed in p63
knockdown when compared with control keratinocytes
(Figure 2b). Similarly, higher expression levels of miR-34a
and miR-34c were found in p63-null embryonic skin at E14.5
when compared with wild-type littermates (Figure 2d),
indicating that p63 negatively regulates miR-34a and miR-
34c expression in epidermal cells in vitro and in vivo. To
explore the possibility that p63 may directly regulate miR-34a
and miR-34b/c, chromatin immunoprecipitation analysis
using p63-specific antibodies was performed in primary
mouse keratinocytes. p63 strongly bound to miR-34a and
miR-34b/c promoters containing phylogenetically conserved
p53-binding sites (Figure 3a and Supplementary Figure S2
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Figure 1. p63 regulates cell cycle progression of mouse epidermal cells independently of p53. (a) BrdU analysis performed in primary mouse keratinocytes
transfected with p63 or with negative control short interfering RNA (siRNA; ctr; left panel), or in parallel infected with a retrovirus carrying DNp63a or control
(green fluorescent protein (GFP)) as indicated (right panel). (b) Cell cycle profiles generated by flow cytometry analysis of propidium iodide–stained primary
mouse keratinocytes 48 hours after transfection with p63 or ctr siRNA. White bars represent the G1 phase of the cell cycle, gray bars the S phase, and black
bars the G2/M phase. (c) BrdU analysis performed in p53 knockout (KO) and wild-type (WT) primary mouse keratinocytes transfected with p63 or negative
control siRNA. (d) Immunofluorescence analysis using antibodies specific for BrdU (in red) in dorsal skin of p63 and/or p53 KO and WT embryos at E14.5.
Nuclei were stained with 4,6-diamidino-2-phenylindole (DAPI; blue). The percentage of BrdU-incorporating cells compared with the total amount of nuclei
in the epidermis and relative SD are indicated. Scale bar¼ 50 mm. Results are representative of at least two independent experiments±SD. (e) p63 knockdown
alters the expression of a subset of cell cycle regulators. Total protein extracts were collected from primary mouse keratinocytes at the indicated time points
upon transfection of p63, control (ctr), or unrelated control (ctr2) siRNAs. Extracts from untransfected cells () were also loaded as control. Immunoblots
were incubated with the indicated antibodies. Equal loading was confirmed by extracellular signal-regulated kinase (ERK) expression. Results are representative
of two independent experiments.
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online). In addition, p63 overexpression significantly inhibited
the activity of miR-34a and miR34b/c promoters, whereas
p63 knockdown resulted in an enhancement of their activity
(Figure 3b).
Taken together, these data indicate that miR-34a and
miR-34c are expressed in a spatially discrete manner in
the epidermis, and are transcriptionally repressed by p63.
miR-34 downregulation counteracts cell cycle arrest in the
absence of p63
To test the contribution of miR-34 family in the cell cycle
arrest elicited by loss of p63, we co-transfected antisense
inhibitors (anti-miR) for miR-34a, miR-34c, or both in the
presence or absence of p63 (Figure 4a). Consistent with
previous experiments, DNA synthesis was strongly impaired
in p63 knockdown keratinocytes, whereas transfection with
anti-miR-34a or anti-miR-34c partially restored DNA synth-
esis (Figure 4b). Concomitant transfection of both anti-miR-
34a and anti-miR-34c almost entirely rescued the proliferation
defect in the absence of p63, whereas they had no effect on
DNA synthesis in the presence of p63. Interestingly,
concomitant downregulation of miR-34a and miR-34c also
resulted in a decreased number of cells with morphological
alterations due to the absence of p63, whereas it had no effect
in the presence of p63 (Figure 4c).
The miR-34 family has been shown to regulate cell cycle
progression in G1 phase by directly controlling a number of
cell cycle regulators including cyclin D1 and Cdk4 (He et al.,
2007; Sun et al., 2008). To test whether miR-34 family exerts
an effect downstream of p63 to regulate the expression of cell
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Figure 2. miR-34a and miR-34c are specifically expressed in mouse epidermis and are induced by loss of p63. (a) Expression levels of the indicated microRNA
(miRNA) were measured using real-time quantitative reverse transcriptase-PCR (RT-PCR; Taqman) in primary mouse keratinocytes. miRNA samples were
normalized to U6 small nuclear RNA (snRNA) expression levels. (b) miR-34a and miR-34c levels were measured using real-time quantitative RT-PCR in primary
mouse keratinocytes transfected with p63 or control short interfering RNAs (ctr siRNAs). (c) In situ hybridization performed in mouse newborn skin
sections using digoxigenin (DIG)-labeled anti-miR probes specific for miR-34a, miR-34b, and miR-34c. Scale bar¼ 50 mm. (d) miR-34a and miR-34c levels
were measured using real-time quantitative RT-PCR in E14.5 skin of wild-type (WT) and p63 knockout (KO) embryos.
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cycle proteins, we measured the protein levels of a subset of
cell cycle regulators in the presence or absence of p63 and
miR-34 family. p63 knockdown inhibited the expression of
cyclin D1, CDK4, and to a lesser extent CDK2. Concomitant
downregulation of both miR-34a and miR-34c resulted in a
significant rescue of the expression of cyclin D1 and CDK4,
the two known miR-34 targets, whereas CDK2 remained
unaffected (Figure 5). Taken together, these data indicate that
miR-34a and miR-34c are relevant targets of p63 in cell cycle
regulation.
DISCUSSION
We report that under physiological conditions p63 maintains
cell cycle progression in mouse basal epidermal cells in a
p53-independent manner, consistent with a strong DNp63a
expression and very low p53 levels in basal keratinocytes.
The reduced rate of DNA synthesis in p63-null embryonic
epidermis is not as dramatic as the one observed in vitro,
suggesting that other compensatory mechanisms are likely to
overcome the proliferation defect in the context of the skin
tissue. Beside impaired proliferation, defective stratification
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Figure 4. Concomitant downregulation of miR-34a and miR-34c expression
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(Koster et al., 2004; Mills et al., 1999), and possibly cell
adhesion (Carroll et al., 2006), significantly contribute to
severe epidermal phenotype that is observed at birth in p63-
null mice. We show that a relevant mechanism through
which p63 regulates G1-to-S-phase transition is by direct
repression of the previously reported p53 targets miR-34a and
miR-34c. Other p53 target genes, such as p21Cip1 and 14-3-
3s (Westfall et al., 2003; Nguyen et al., 2006; Truong et al.,
2006), are repressed by p63 and are likely to contribute to
p63-mediated cell cycle progression. Thus, p63—more
specifically its DNp63a isoform—and p53 regulate a set of
target genes involved in cell proliferation in an opposing
manner, by which p63 binding represses genes that cause cell
cycle arrest and p53 activates them. The role of p53 in p63-
mediated cell cycle progression in keratinocytes is contro-
versial. Simultaneous p63 and p53 knockdown in human
keratinocytes rescued the cell proliferation defect in the
absence of p63 in one study, possibly due to high p53
expression levels in that setting (Truong et al., 2006), whereas
regulation of cell cycle progression by p63 was found to be
independent of p53 and p73 in another study (Deyoung et al.,
2006). Our data indicate that in mouse epidermal cells p53
does not contribute to cell cycle arrest due to loss of p63 at
least in the absence of DNA damage.
In human keratinocytes, p21Cip1 expression was elevated
(Deyoung et al., 2006; Truong et al., 2006), but its
downregulation was insufficient to restore cell proliferation
in the absence of p63. We previously reported upregulation
of p21Cip1 upon p63 downregulation in Sencar keratinocytes
(Nguyen et al., 2006), whereas in the CD1 background
p21Cip1 expression is not induced, further reinforcing the
notion that p21Cip1 is unlikely to be the only player in cell
cycle arrest downstream of p63. Similar to other cell cycle
regulators, the downregulation of p21Cip1 observed at late
time points upon p63 knockdown is likely to be a
consequence of cell cycle arrest. Other p63 target genes
are likely to contribute to cell cycle progression as p63
transcriptionally regulates a large number of downstream
targets (Vigano et al., 2006; Yang et al., 2006; Della Gatta
et al., 2008). Among the cyclin-dependent kinase inhibitors,
p16Ink4a is induced in p63-null skin (Keyes et al., 2005; Su
et al., 2009), and the skin phenotype of p63-null mice is
ameliorated by loss of p16Ink4a with partial restoration of
keratinocyte proliferation (Su et al., 2009). Future experi-
ments will need to address the contribution of miR-34 to cell
cycle regulation by p63 in vivo, and in human keratinocytes.
Our data indicate that miR-34 downregulation leads to
induced expression of cyclin D1 and CDK4 in the absence of
p63. Both cyclin D1 and CDK4 are direct targets of miR-34;
however, previously reported G1-phase regulators whose
expression is controlled by miR-34 also include CDK6, E2F3,
cyclin D3, and cyclin E2 (Bommer et al., 2007; He et al.,
2007; Tazawa et al., 2007; Sun et al., 2008). Given that each
miRNA is predicted to bind to more than 100 target mRNAs,
p63 is likely to control a large set of cell cycle regulators by
directing repressing miR-34 family.
We find a strong and specific expression of miR-34a in the
epidermis and in the hair follicle, with a more intense signal
in the suprabasal layers than in the basal layer, consistent
with the reciprocal expression of p63. More puzzling is the
prevalent expression of miR-34c in the basal layer of the
epidermis, which is consistent with the notion that other
epidermal-specific transcription factors beside p63 are likely
to regulate miR-34 expression in the epidermis. In addition to
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Figure 5. Concomitant downregulation of miR-34a and miR-34c expression
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its elevated expression in the epithelial component of the
skin, miR-34a is highly expressed in the brain, with variable
expression in other tissues (Bommer et al., 2007). In contrast,
miR-34c is most highly expressed in lung, with low
expression in brain and very low to undetectable expression
in other tissues. Expression of miR-34b in normal mouse
tissues parallels miR-34c expression (Bommer et al., 2007),
consistent with the fact that they share the same precursor
transcript. Interestingly, we find that miR-34c is expressed
in skin whereas miR-34b is not, as shown using Taqman
assay and in situ hybridization, suggesting that their
maturation may be different. Post-transcriptional regulation
for a large fraction of miRNAs has been shown at the Drosha
processing step. It has been recently shown that p53
modulates miRNA processing by functional interaction with
the Drosha processing complex through binding of the DEAD
box RNA helicases p68 (Suzuki et al., 2009). Interestingly,
p53 binds p68 through a carboxy terminal portion of the
DNA-binding domain, which is highly homologous to the
corresponding region in p63. Thus, an outstanding question
for future studies will be whether p63 shares with p53 the
ability to bind p68 and interfere with miRNA maturation.
An important role of miRNA in skin has been previously
uncovered. Conditional targeting of Dicer or of Dgcr8 in skin
epithelium results in a severe phenotype, including altered
barrier function of epidermis and hair follicle that fail to
invaginate (Andl et al., 2006; Yi et al., 2006, 2009; Yi and
Fuchs, 2009). In addition, inducible conditional knockout of
Dicer after hair follicle maturation leads to epidermal
thickening (Yi et al., 2008). miRNA-203 is induced in the
skin concomitantly with stratification and differentiation, and
promotes epidermal differentiation by restricting proliferative
potential and inducing cell cycle exit in both human and
mouse keratinocytes (Lena et al., 2008; Yi et al., 2008). miR-
203 directly represses the expression of p63, which fails to
switch off suprabasally when either Dicer1 or miR-203 is
absent. p63 becomes repressed basally when miR-203 is
prematurely expressed. This study suggest the possibility that
a regulatory axis exists in the skin, by which miR-203 and
miR-34 family are, respectively, upstream and downstream of
p63 to control cell proliferation.
MATERIALS AND METHODS
Cell cultures, transfections, retroviral preparation, and mice
Primary mouse keratinocytes were isolated from 2-day-old Swiss
ICR(CD-1) mice (Harlan Laboratories, Udine, Italy) and cultured
under low Ca2þ conditions as previously described (Antonini et al.,
2006). Transfections were performed 5 days after plating. A total
amount of 200 nM siRNA (Stealth siRNA, Invitrogen) for p63
(Antonini et al., 2008), or control medium GC-rich siRNA (Stealth
siRNA, Invitrogen, Milano, Italy), and/or anti-miR-34a, anti-miR-34c
(miRCURY, Exiqon, Vedbaek, Denmark), or scramble control
(miRCURY, Exiqon 19900200) were transfected using Lipofectamine
2000 (Invitrogen) as described earlier (Antonini et al., 2006). Stealth
RNA interference negative control medium GC (Invitrogen) and an
alternative RNA interference (50-ACAGCTACATCGCGCTCATCGC
TAT-30) were used as negative controls as indicated. Primary
keratinocytes were infected with high-titer GINCO-green-fluorescent
protein or GINCO-DNp63a retroviruses (Della Gatta et al., 2008) and
were cultured for 4 additional days. p63-null mice (B6.129S7-
Trp63tm1Brd/J) were obtained from Jackson Laboratory (Bar Harbor,
ME). p53-null mice (Donehower et al., 1992) in a C57/BL6 back-
ground were obtained from Alfredo Fusco (Federico II University,
Napoli, Italy). All experiments performed with mice were conducted
under the approvalinstitutional animal care and use committee.
Flow cytometry and BrdU labeling
For cell cycle analysis, keratinocytes were harvested 48 hours after
transfection and were incubated with a solution of propidium iodide
(Sigma-Aldrich; St Louis, MO; 2.5mgml–1), RNAse (1mgml–1), and
0.15% NP-40 in phosphate-buffered saline overnight at 4 1C. For
each sample, at least 10,000 events were acquired using FACSCanto II
Flow Cytometry System (BD Biosciences, Erembodegem,
Belgium), and analyzed using the ModFit LT 3.0 software (Verity
Software House, Topsham, ME). For measurement of DNA synthesis,
cells were labeled with BrdU (Zymed, San Francisco, CA; 1:100) for
3 hours and stained as previously described (Della Gatta et al.,
2008). For in vivo analysis, BrdU was injected (1ml per 100 g body
weight) intraperitoneally in pregnant female mice and incubated for
3 hours. Embryos were taken at E14.5 and fixed in 4% paraformal-
dehyde, and embedded in paraffin. Sections, 7mm thick, were
permeabilized in 0.2% Triton X-100, and processed for immuno-
fluorescence as described above.
miRNA expression analysis and in situ hybridization
Total RNA from primary keratinocytes or from total embryonic skin
was extracted using TRIzol reagent (Invitrogen). The expression
levels of mature miRNA species were quantified using TaqMan
MicroRNA Assays (Applied Biosystems, Foster City, CA; miR-34a:
no. 4373278; miR-34b: no. 4373343, and miR-34c: no. 4373036).
The expression of each miRNA was normalized to the expression of
U6 small nuclear RNA.
In situ hybridization was performed essentially as previously
described (Brancaccio et al., 2004). Hybridization was performed
with miRCURY LNA Detection antisense Probes (Exiqon) specific for
miR-34a, miR-34b, and miR-34c at 40 1C. Digoxigenin labeling was
monitored under a Zeiss Axioskop2 plus microscope using a Zeiss
Plan-Neofluar (Zeiss, Arese, Italy)  20/0.50 objective.
Immunoblotting
Cells were lysed in Laemmli sample buffer and protein extracts were
run on SDS-PAGE gels, transferred on Immobilon-P transfer
membranes (Millipore, Milano, Italy), probed with the indicated
antibodies and detected using enhanced chemiluminescence (GE
Healthcare Life Sciences, Milano, Italy). The following primary
antibodies were used for immunoblotting analysis: p63 (4A4), cyclin
D1 (72-13G), Cdk2 (M-2), Cdk4 (C-22), and ERK-1 (K-23), all from
Santa Cruz Biotechnology (Heidelberg, Germany). For quantification
of immunoblotting, exposed films were scanned using ChemiDoc
(Bio-Rad, Hercules, CA) and quantified using ImageJ software (http://
rsbweb.nih.gov/ij/).
Chromatin immunoprecipitation
Primary keratinocytes were fixed with 1% formaldehyde and
chromatin immunoprecipitation/real-time PCR was performed
using anti-p63 antibodies (H-137, Santa Cruz Biotechnology), and
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non-specific rabbit IgG antibodies as negative control. Chromatin
immunoprecipitation and real time PCR were performed as
previously described (Antonini et al., 2008). Oligonucleotide
primers used for real-time PCR amplifications were: miR-34a
promoter: F: 50-CAGCCTGGAGGAGGATCGA-30, R: 50-TTCTCT
GAACAAGTCCAGGCAA-30; miR-34b/c promoter F: 50-CTGTTGA
TCCTGCCCACAGTT-30, R: 50-GCATGACCAGCAGATGCAAT-30.
Luciferase assay was performed as previously described (Antonini
et al., 2008).
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